It's good to have a choice; now let's get more data: Response to Armstrong et al.'s "Response to Lai et al., development of a symptom index for patients with primary brain tumors"

Jin Shei Lai; David Cella; Jennifer Beaumont

doi:10.1016/j.jval.2014.07.004

It's good to have a choice; now let's get more data: Response to Armstrong et al.'s "Response to Lai et al., development of a symptom index for patients with primary brain tumors"

Jin Shei Lai^*, David Cella, Jennifer Beaumont

^*Corresponding author for this work

Medical Social Sciences

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	754-755
Number of pages	2
Journal	Value in Health
Volume	17
Issue number	6
DOIs	https://doi.org/10.1016/j.jval.2014.07.004
State	Published - Sep 1 2014

Funding

Source of Financial Support: This project was supported by Amgen, AstraZeneca Pharmaceuticals, Bayer, Bristol-Myers Squibb, Centocor, Cell Therapeutics, Inc., Genentech, Eli Lilly and Company, Merck & Company, Novartis, Ortho Biotech, Pfizer, Sanofi-Aventis, and Takeda Pharmaceuticals.

ASJC Scopus subject areas

Health Policy
Public Health, Environmental and Occupational Health

Access to Document

10.1016/j.jval.2014.07.004

Cite this

@article{62a9641a06734e27a3569e21a0adf018,

title = "It's good to have a choice; now let's get more data: Response to Armstrong et al.'s {"}Response to Lai et al., development of a symptom index for patients with primary brain tumors{"}",

author = "Lai, \{Jin Shei\} and David Cella and Jennifer Beaumont",

note = "Funding Information: Source of Financial Support: This project was supported by Amgen, AstraZeneca Pharmaceuticals, Bayer, Bristol-Myers Squibb, Centocor, Cell Therapeutics, Inc., Genentech, Eli Lilly and Company, Merck \& Company, Novartis, Ortho Biotech, Pfizer, Sanofi-Aventis, and Takeda Pharmaceuticals. ",

year = "2014",

month = sep,

day = "1",

doi = "10.1016/j.jval.2014.07.004",

language = "English (US)",

volume = "17",

pages = "754--755",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Ltd",

number = "6",

}

TY - JOUR

T1 - It's good to have a choice; now let's get more data

T2 - Response to Armstrong et al.'s "Response to Lai et al., development of a symptom index for patients with primary brain tumors"

AU - Lai, Jin Shei

AU - Cella, David

AU - Beaumont, Jennifer

N1 - Funding Information: Source of Financial Support: This project was supported by Amgen, AstraZeneca Pharmaceuticals, Bayer, Bristol-Myers Squibb, Centocor, Cell Therapeutics, Inc., Genentech, Eli Lilly and Company, Merck & Company, Novartis, Ortho Biotech, Pfizer, Sanofi-Aventis, and Takeda Pharmaceuticals.

PY - 2014/9/1

Y1 - 2014/9/1

UR - https://www.scopus.com/pages/publications/84908164839

UR - https://www.scopus.com/inward/citedby.url?scp=84908164839&partnerID=8YFLogxK

U2 - 10.1016/j.jval.2014.07.004

DO - 10.1016/j.jval.2014.07.004

M3 - Letter

C2 - 25237002

AN - SCOPUS:84908164839

SN - 1098-3015

VL - 17

SP - 754

EP - 755

JO - Value in Health

JF - Value in Health

IS - 6

ER -

It's good to have a choice; now let's get more data: Response to Armstrong et al.'s "Response to Lai et al., development of a symptom index for patients with primary brain tumors"

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this